Osimertinib With or Without Primary Lung Tumor Resection for EGFR-Mutant Oligometastatic Non-Small Cell Lung Cancer
Clinical trial NCT07738172 · RECRUITING
Trial details
- NCT number
- NCT07738172
- Sponsor
- National Taiwan University Hospital
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-08-01
- Primary completion
- 2031-08-01
- Enrollment
- 154
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.